STAT+: Trump officials push for skimpier coverage in ACA ...

What’s Happening

Breaking it down: The Trump administration wants the 2027 ACA marketplace to offer plans with lower premiums — but the tradeoff is high deductibles and risk for those needing care.

Business Business STAT Plus: Humana projects sharply lower earnings as Medicare membership surges By Tara Bannow The Readout The Readout STAT Plus: The unusual Prasad missive in the FDAs rejection of the Moderna flu shot app By Meghana Keshavan Business Business STAT Plus: Hims is in the crosshairs. Is a crackdown coming for compounding? (plot twist fr)

Diagnosis STAT Plus: TrumpRx: Hype or real savings?

Why This Matters

By John Wilkerson The Readout The Readout STAT Plus: Evommune reports positive mid-stage data for eczema drug By Meghana Keshavan STAT Plus: Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock By Jason Mast STAT Plus: A rival goes after Ocular Therapeutix on eve of pivotal readout on eye treatment By Adam Feuerstein STAT Plus: Nektar Therapeutics is trying to stage a comeback.

Health experts are weighing in on what this means for people.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

What’s your take on this whole situation?